• Latest Posts

U.S. approval for psychedelic drug MDMA nears after success in clinic

Beckley Psytech acquires Eleusis Therapeutics

Spinoff Biohaven launches with $258M and “incredible pipeline”

Drug for acute treatment of social anxiety disorder did not meet primary endpoint

The top psychedelic drug developers leading the market


Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood

Slow-Release Drug Biotech IPO Raises €30M

Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner

British Researchers Find Thought Police to Treat Neurological Disorders

Austrian Researchers build an improved Mini-Brain to support Psychiatry